CLINICAL TRIALS PROFILE FOR VECURONIUM BROMIDE
✉ Email this page to a colleague
All Clinical Trials for VECURONIUM BROMIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00970762 ↗ | Comparative Study of Rocuronium With Vecuronium (Study 71101)(COMPLETED) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2003-02-01 | This study was conducted to determine and compare the safety and effectiveness of two neuromuscular blockers (rocuronium and vecuronium) at various doses in adults who are undergoing general elective surgery with sevoflurane anesthesia. Study participants received an intubating dose of a neuromuscular blocker (to enable insertion of a tube through the nose or mouth into the trachea to provide artificial ventilation). The intubating dose was followed by repeated bolus maintenance doses as needed, to maintain muscle relaxation. The time it takes to reach maximal effect of the neuromuscular blocker (onset time) after the intubating dose was measured and compared as the primary outcome. |
| NCT01116713 ↗ | Effect of Dexamethasone in Postoperative Symptoms After Mastectomy for Breast Cancer | Completed | Instituto Mexicano del Seguro Social | Phase 3 | 2009-06-01 | Postoperative pain, nausea and vomiting (PONV) are the most common complications after anesthesia and surgery. Women undergoing mastectomy with axillary dissection are at a particularly high risk for the development of PONV and an incidence of 60-80% in patients receiving no antiemetic has been reported. Emetic episodes predispose to aspiration of gastric contents, wound dehiscence, psychological distress, and delayed recovery and discharge times. These justify the use of prophylactic antiemetics in women scheduled for mastectomy. Most of the currently used antiemetics, including antihistamines, butyrophenones and dopamine receptor antagonists have been reported to cause occasional undesirable adverse effects, such as excessive sedation, hypotension, dry mouth, dysphoria, hallucinations and extrapyramidal signs. Antiserotonins (e.g., ondansetron) are available for the prevention and treatment of PONV in patients undergoing various types of surgery [4]. However, the use of prophylactic antiemetic therapy with antiserotonins has been criticized for being too expensive. Dexamethasone was first reported to be an effective antiemetic regimen in patients receiving cancer chemotherapy. The purpose of this study was to evaluate the efficacy of dexamethasone treatment for reducing pain and PONV as well as analgesic and antiemetic requirements in women undergoing general anesthesia for mastectomy with axillary lymph node dissection. |
| NCT01690338 ↗ | A Study of Residual Curarization Incidence in China | Unknown status | Central South University | Phase 4 | 2012-10-01 | The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors. |
| NCT01690338 ↗ | A Study of Residual Curarization Incidence in China | Unknown status | China Medical University Hospital | Phase 4 | 2012-10-01 | The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VECURONIUM BROMIDE
Condition Name
Clinical Trial Locations for VECURONIUM BROMIDE
Trials by Country
Clinical Trial Progress for VECURONIUM BROMIDE
Clinical Trial Phase
Clinical Trial Sponsors for VECURONIUM BROMIDE
Sponsor Name
